Home ENGLISH Page 3

ENGLISH

Latest

Woodford suspends trading in flagship fund after investors flee

admin -
0

Jazz Pharma nabs Immunomedics’ Iannone as R&D chief

admin -
0

ASCO: Viracta’s HDAC-inhibitor combo garners high response in EBV-linked lymphoma

admin -
0

Nose drop with adult stem cells restores sense of smell in mice

admin -
0

ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR

admin -
0

ASCO: With FDA review nearing, Epizyme shares updated sarcoma data

admin -
0

GE Healthcare executive jumps ship to lead dermatology biotech LEO

admin -
0

Ayala’s ex-BMS drug shows promise in triple-negative breast cancer

admin -
0

Complete response rate in Nektar melanoma trial hits 34%

admin -
0

Aslan retools CSL deal, taking control of would-be Dupixent rival

admin -
0

China’s Fosun pulls back from U.S. biotech scene

admin -
0

ASCO 2019 preview: Big Pharmas looking for cancer R&D revival as we hit next-gen...

admin -
0

Chutes & Ladders—Novartis’ Kymriah head jumps ship to Atara

admin -
0

Sanofi hires ex-Genentech SVP Berger to head development

admin -
0

Audentes loses two executives, hires Sangamo CMO to fill vacancy

admin -
0

With $110M and Johns Hopkins tech, Thrive aims to make early cancer screening routine

admin -
0

Novartis’ Kymriah head jumps ship to T-cell biotech Atara as its R&D chief quits

admin -
0

Novartis powers Notch cancer biotech Ayala to $30M series B

admin -
0
1234...1,499Page 3 of 1,499
©